• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CDC - Two Cases of Monkeypox-Associated Encephalomyelitis — Colorado and the District of Columbia, July–August 2022

Mary Wilson

Well-known member
Early Release / September 13, 2022 / 71

http://dx.doi.org/10.15585/mmwr.mm7138e1

Daniel M. Pastula, MD[SUP]1,[/SUP]*; Matthew J. Copeland, DO[SUP]2,[/SUP]*; Markus C. Hannan, MD[SUP]3[/SUP]; Samuel Rapaka, DO[SUP]2[/SUP]; Takashi Kitani, MD[SUP]4[/SUP]; Elizabeth Kleiner, MD[SUP]3[/SUP]; Adrienne Showler, MD[SUP]2[/SUP]; Cindy Yuen, DO[SUP]3[/SUP]; Elizabeth M. Ferriman[SUP]3[/SUP]; Jennifer House, DVM[SUP]5[/SUP]; Shannon O’Brien, MD[SUP]5[/SUP]; Alexis Burakoff, MD[SUP]5[/SUP]; Bhavik Gupta, DO[SUP]6[/SUP]; Kelli M. Money, MD, PhD[SUP]1[/SUP]; Elizabeth Matthews, MD[SUP]1[/SUP]; J. David Beckham, MD[SUP]1[/SUP]; Lakshmi Chauhan, MD[SUP]1[/SUP]; Amanda L. Piquet, MD[SUP]1[/SUP]; Rebecca N. Kumar, MD[SUP]2[/SUP]; Carlo S. Tornatore, MD[SUP]4[/SUP]; Kia Padgett, MPH[SUP]7[/SUP]; Kevin O’Laughlin, MD[SUP]7[/SUP]; Anil T. Mangla, PhD[SUP]8[/SUP]; Princy N. Kumar, MD[SUP]2[/SUP]; Kenneth L. Tyler, MD[SUP]1[/SUP]; Siobhán M. O’Connor, MD[SUP]7[/SUP]

Summary

What is already known about this topic?

Monkeypox virus (MPXV) typically causes a febrile illness with lymphadenopathy and a diffuse vesiculopustular rash; neurologic complications are rare. The current monkeypox outbreak differs clinically and epidemiologically from previous outbreaks, and little is known about potential associated neurologic complications.

What is added by this report?

Two U.S. cases of encephalomyelitis associated with acute MPXV infection were identified during summer 2022. Whether the underlying pathophysiology resulted from direct viral neuroinvasion or a parainfectious autoimmune process is currently unknown.

What are the implications for public health practice?

Suspected cases of neurologic complications of monkeypox should be reported to state, tribal, local, or territorial health departments to improve understanding of the range of clinical manifestations of MPXV infections during the current outbreak and treatment options.

... Details of two cases of encephalomyelitis associated with monkeypox in previously healthy young gay men in Colorado and DC are presented in this report. The University of Colorado and Georgetown University determined that this report was not subject to human subjects review because it includes only information obtained for purposes of patient clinical care and public health outbreak response. This activity was also reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.[SUP]†

https://www.cdc.gov/mmwr/volumes/71/wr/mm7138e1.htm#suggestedcitation[/SUP]
 
Back
Top